Showing results (191-200 of 1,479) with videos related to
Sort By:
Pageof 148
Human Psychopharmacology|June 22, 2017
Fentanyl novel derivative-related deathsArianna Giorgetti, Carmela Centola, Raffaele GiorgettiHuman Psychopharmacology|June 21, 2017
Impact of synthetic cannabinoids on the duration of opioid-related withdrawal and craving among patients of addiction clinics in Kazakhstan: A prospective case-control studyMariya Prilutskaya, Francesco Saverio Bersani, Ornella Corazza, et al.Human Psychopharmacology|June 10, 2017
The challenge of complex drug use: Associated use of codeine-containing medicines and new psychoactive substances in a European cross-sectional online populationAndreas Kimergård, Michelle Foley, Zoe Davey, et al.Human Psychopharmacology|June 3, 2017
Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or durationJeffrey Guina, Sayon Roy, Ankur Gupta, et al.Human Psychopharmacology|December 27, 2005
Reviewing the use of antipsychotic drugs in people with intellectual disabilityGiampaolo La Malfa, Stefano Lassi, Marco Bertelli, et al.Human Psychopharmacology|May 19, 2017
Is there a potential of misuse for Magnolia officinalis compounds/metabolites?Fabrizio Schifano, Valentina Guarino, Duccio G Papanti, et al.Human Psychopharmacology|May 19, 2017
Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational studyTiziano Acciavatti, Matteo Lupi, Rita Santacroce, et al.Human Psychopharmacology|April 21, 2018
The effects of acute alcohol withdrawal on sleepChristopher J Hodges, Rowan P Ogeil, Dan I LubmanHuman Psychopharmacology|June 8, 2018
A preliminary investigation into the effects of doxazosin on cognitive functioning in tobacco-deprived and -satiated smokersWalter Roberts, Terril L Verplaetse, Kelly E Moore, et al.Human Psychopharmacology|June 29, 2018
Pharmacogenetic evaluation of a DISP1 gene variant in antidepressant treatment of obsessive-compulsive disorderAmanda J Lisoway, Gwyneth Zai, Arun K Tiwari, et al.Pageof 148